ImaRX Therapeutics is a groundbreaking biopharmaceutical company, pioneering advanced micro bubble technology to target vascular disorders. Founded in 1999, the company focuses on developing innovative therapies for various vascular conditions, particularly stroke, by addressing vascular occlusions and the consequent ischemia. Its recent $7.00M Venture Round investment on 11 March 2005 reflects investor confidence in its cutting-edge approach. Specializing in Biotechnology and Health Care, ImaRX Therapeutics holds promise in transforming the landscape of vascular disorder treatments.
ImaRX Therapeutics
Discover novel therapies for vascular disorders with advanced micro bubble technology.
Founded 1999
Series Unknown
Total: $7.00M
Biotechnology, Health Care +1
General Information
Get notified when ImaRX Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track ImaRX Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Biotechnology
About ImaRX Therapeutics
Taxonomy: biopharmaceutical, vascular disorders, micro bubble technology, therapies, stroke treatment, research-focused, ischemia, vascular occlusions
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 11 Mar 2005 |
ImaRX Therapeutics Alternatives & Competitors
ImaRX Therapeutics vs
Pacific Vascular, Inc.
United States
Specialists in Diagnostic Vascular Ultrasound
74 employees
Health Care
ImaRX Therapeutics vs
ImaRX Therapeutics vs
Society for Vascular Surgery
United States
Advancing excellence and innovation in vascular health through education, advocacy, research and pub...
107 employees
Health Care
FAQ About ImaRX Therapeutics
Discover novel therapies for vascular disorders with advanced micro bubble technology.
ImaRX Therapeutics was founded in 1999.
ImaRX Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
ImaRX Therapeutics has completed 1 funding round, raising a total of $7.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to ImaRX Therapeutics include Pacific Vascular, Inc., Vascular Health Clinics, Society for Vascular Surgery, European Society for Vascular Surgery, Vascular Therapies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ImaRX Therapeutics and Pacific Vascular, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors ImaRX Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.